AZTREONAM Side Effects

6986003-1 | Haemoptysis
on Sep 03, 2010 Female patient from UNITED STATES , weighting 107.8 lb, was diagnosed with cystic fibrosis, cystic fibrosis lung, rhinitis allergic, asthma (What is asthma?), cystic fibrosis hepatic disease, pancreatic insufficiency and was treated with Aztreonam (View Usage). Patient experienced the following unwanted or unexpected effects: haemoptysis. Aztreonam dosage: . During the same period patient was treated with AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), PULMOZYME (View Pulmozyme Review and Pulmozyme Label ), SINGULAIR (View Singulair Review and Singulair Label ), SYMBICORT (View Symbicort Review and Symbicort Label ), XOPENEX (View Xopenex Review and Xopenex Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), ACTIGALL (View Actigall Review and Actigall Label ), ADEK (View Adek Review and Adek Label ). Patient was hospitalized.

6934691-8 | Abortion Spontaneous, Premature Labour, Twin Pregnancy
Patient was taking Aztreonam (View Usage). Patient had the following side effects: abortion spontaneous, premature labour, twin pregnancy on Aug 11, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 114.0 lb, was diagnosed with cystic fibrosis and. Aztreonam dosage: . During the same period patient was treated with ACETYLCYSTEINE (View Acetylcysteine Review and Acetylcysteine Label ), ALBUTEROL SULFATE (View Albuterol Sulfate Review and Albuterol Sulfate Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), CREON (View Creon Review and Creon Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), BACTRIM DS (View Bactrim Ds Review and Bactrim Ds Label ), MEPHYTON (View Mephyton Review and Mephyton Label ).

6884173-7 | Lung Disorder
Adverse event was reported on Jul 20, 2010 by a Female patient taking Aztreonam (View Usage) (Dosage: ) was diagnosed with cystic fibrosis and. Location: UNITED STATES , weighting 70.55 lb, After Aztreonam was administered, patient had the following side effects: lung disorder. During the same period patient was treated with ZYVOX (View Zyvox Review and Zyvox Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), PULMOZYME (View Pulmozyme Review and Pulmozyme Label ), HYPERTONIC SALINE (View Hypertonic Saline Review and Hypertonic Saline Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), SINGULAIR (View Singulair Review and Singulair Label ), FLOVENT (View Flovent Review and Flovent Label ).

6775657-0 | Haemoptysis
on Jun 07, 2010 Male patient from UNITED STATES , weighting 159.9 lb, was diagnosed with cystic fibrosis, cystic fibrosis lung, asthma (What is asthma?) and was treated with Aztreonam (View Usage). Patient experienced the following unwanted or unexpected effects: haemoptysis. Aztreonam dosage: . During the same period patient was treated with ZITHROMAX (View Zithromax Review and Zithromax Label ), XOPENEX (View Xopenex Review and Xopenex Label ), PULMOZYME (View Pulmozyme Review and Pulmozyme Label ), IPRATROPIUM BROMIDE (View Ipratropium Bromide Review and Ipratropium Bromide Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ). Patient was hospitalized.


6765091-1 | White Blood Cell Count Decreased
on Jun 09, 2010 Male patient from UNITED STATES , 75 years of age, weighting 154.3 lb, was diagnosed with sepsis (What is sepsis?), urinary tract infection (What is urinary tract infection?) and was treated with Aztreonam (View Usage). Patient had the following side effects: white blood cell count decreased. Aztreonam dosage: 2gm Every 8 Hours Iv.

6740494-X | Lung Disorder
Patient was taking Aztreonam (View Usage). After Aztreonam was administered, patient had the following side effects: lung disorder on May 13, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 70.55 lb, was diagnosed with cystic fibrosis and. Aztreonam dosage: . During the same period patient was treated with ZYVOX (View Zyvox Review and Zyvox Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), PULMOZYME (View Pulmozyme Review and Pulmozyme Label ), HYPERTONIC SALINE (View Hypertonic Saline Review and Hypertonic Saline Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), SINGULAIR (View Singulair Review and Singulair Label ), FLOVENT (View Flovent Review and Flovent Label ). Patient was hospitalized.

6550972-4 | Chest Pain, Dyspnoea, Flushing, Hypersensitivity, Infusion Related Reaction, Pruritus
Adverse event was reported on Jan 22, 2010 by a Female patient taking Aztreonam (View Usage) (Dosage: 1 G Q8h Iv) was diagnosed with pyelonephritis and. Location: UNITED STATES , 59 years of age, weighting 183.0 lb, Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?), dyspnoea, flushing, hypersensitivity, infusion related reaction, pruritus.

6426144-0 | Anaphylactic Reaction
on Nov 03, 2009 Male patient from UNITED STATES , 52 years of age, weighting 191.0 lb, was diagnosed with urinary tract infection (What is urinary tract infection?) and was treated with Aztreonam (View Usage). Patient had the following side effects: anaphylactic reaction. Aztreonam dosage: 1 Gm Bid Iv.

6213289-3 | Liver Function Test Abnormal
on Jun 02, 2009 Male patient from UNITED STATES , 74 years of age, was treated with Aztreonam (View Usage). After Aztreonam was administered, patient had the following side effects: liver function test abnormal. Aztreonam dosage: . Patient was hospitalized.

6187995-3 | Exfoliative Rash, Pain
Patient was taking Aztreonam (View Usage). Patient experienced the following unwanted or unexpected effects: exfoliative rash, pain (What is pain?) on May 11, 2009 from UNITED STATES Additional patient health information: Female patient , 82 years of age, weighting 227.1 lb, was diagnosed with sepsis (What is sepsis?) and. Aztreonam dosage: 1gm Q8h Iv. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), LEVAQUIN (View Levaquin Review and Levaquin Label ), HYDRALAZINE HCL (View Hydralazine Hcl Review and Hydralazine Hcl Label ), SENNA (View Senna Review and Senna Label ). Patient was hospitalized and became disabled.

6163744-X | Anaphylactic Reaction
Adverse event was reported on Apr 20, 2009 by a Female patient taking Aztreonam (View Usage) (Dosage: 500mg Iv Q12 Hours) was diagnosed with urinary tract infection (What is urinary tract infection?) and. Location: UNITED STATES , 86 years of age, Patient had the following side effects: anaphylactic reaction. During the same period patient was treated with SURFAK (View Surfak Review and Surfak Label ), AMIODARONE (View Amiodarone Review and Amiodarone Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), LIPITOR (View Lipitor Review and Lipitor Label ), RAZADYNE (View Razadyne Review and Razadyne Label ), VALIUM (View Valium Review and Valium Label ). Patient was hospitalized.

5963440-5 | Erythema, Rash Maculo-papular
on Nov 21, 2008 Male patient from UNITED STATES , 54 years of age, weighting 208.3 lb, was diagnosed with pneumonia (What is pneumonia?) and was treated with Aztreonam (View Usage). After Aztreonam was administered, patient had the following side effects: erythema, rash maculo-papular. Aztreonam dosage: 2 Gm Iv Q 8 Hrs. During the same period patient was treated with VANCOMYCIN HCL (View Vancomycin Hcl Review and Vancomycin Hcl Label ), RIFAMPIN (View Rifampin Review and Rifampin Label ), APAP TAB (View Apap Tab Review and Apap Tab Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), ETHACRYNIC ACID (View Ethacrynic Acid Review and Ethacrynic Acid Label ), INSULIN (View Insulin Review and Insulin Label ).

5724630-X | Leukopenia, Pericarditis
on Apr 30, 2008 Male patient from UNITED STATES , 39 years of age, weighting 190.3 lb, was diagnosed with liver abscess and was treated with Aztreonam (View Usage). Patient experienced the following unwanted or unexpected effects: leukopenia, pericarditis. Aztreonam dosage: 2gm Iv Q8. During the same period patient was treated with VANCOMYCIN HCL (1 Gm Iv Q12) (View Vancomycin Hcl Review and Vancomycin Hcl Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), PERCOCET (View Percocet Review and Percocet Label ), ITRACONAZOLE (View Itraconazole Review and Itraconazole Label ).

5601621-0 | Diplopia
Patient was taking Aztreonam (View Usage). Patient had the following side effects: diplopia on Jan 30, 2007 from UNITED STATES Additional patient health information: Male patient , 57 years of age, was diagnosed with infection (What is infection?) and. Aztreonam dosage: .

5556848-3 | Rash
Adverse event was reported on Dec 10, 2007 by a Male patient taking Aztreonam (View Usage) (Dosage: 500 Mg Q6hr Iv) was diagnosed with rash (What is rash?) and. Location: UNITED STATES , 60 years of age, weighting 136.7 lb, After Aztreonam was administered, patient had the following side effects: rash (What is rash?). Patient was hospitalized.

5300500-6 | Neutropenia, White Blood Cell Count Decreased
on Apr 13, 2007 Male patient from UNITED STATES , 77 years of age, weighting 199.3 lb, was diagnosed with pneumonia (What is pneumonia?) and was treated with Aztreonam (View Usage). Patient experienced the following unwanted or unexpected effects: neutropenia, white blood cell count decreased. Aztreonam dosage: 2gm Q8h Iv Drip. Patient was hospitalized.

5154081-0 | Rash
on Nov 16, 2006 Male patient from UNITED STATES , 17 years of age, weighting 132.3 lb, was diagnosed with disease recurrence, pyelonephritis and was treated with Aztreonam (View Usage). Patient had the following side effects: rash (What is rash?). Aztreonam dosage: 2 Grams Q12 Iv Bolus One Time Dose. During the same period patient was treated with GENTAMICIN (View Gentamicin Review and Gentamicin Label ), LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), OXYCODONE/ACETAMINOPHEN (View Oxycodone/acetaminophen Review and Oxycodone/acetaminophen Label ).

4945345-1 | Rash Maculo-papular
Patient was taking Aztreonam (View Usage). After Aztreonam was administered, patient had the following side effects: rash maculo-papular on Mar 15, 2006 from UNITED STATES Additional patient health information: Male patient , 59 years of age, weighting 165.3 lb, was diagnosed with pneumonia (What is pneumonia?) and. Aztreonam dosage: 500mg Iv Q 8 Hours. During the same period patient was treated with CLINDAMYCIN (600mg Iv Q 6 Hours) (View Clindamycin Review and Clindamycin Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), BACLOFEN (View Baclofen Review and Baclofen Label ), DOCUSATE (View Docusate Review and Docusate Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), LOVASTATIN (View Lovastatin Review and Lovastatin Label ). Patient was hospitalized.

4837407-4 | Dyspnoea, Pharyngeal Oedema, Pruritus, Rash, Refusal Of Treatment By Patient, Swollen Tongue
Adverse event was reported on Nov 23, 2005 by a Male patient taking Aztreonam (View Usage) (Dosage: 2 Gm Iv Q 8 Hrs) was diagnosed with infection (What is infection?) and. Location: UNITED STATES , 65 years of age, weighting 176.4 lb, Patient experienced the following unwanted or unexpected effects: dyspnoea, pharyngeal oedema, pruritus, rash (What is rash?), refusal of treatment by patient, swollen tongue. During the same period patient was treated with TOBRAMYCIN (View Tobramycin Review and Tobramycin Label ).

4825231-8 | Rash
on Nov 09, 2005 Male patient from UNITED STATES , 73 years of age, weighting 196.2 lb, was diagnosed with bacterial infection (What is bacterial infection?) and was treated with Aztreonam (View Usage). Patient had the following side effects: rash (What is rash?). Aztreonam dosage: 2 Gram Iv Q 8 H. During the same period patient was treated with METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), ACETYLCYSTEINE (View Acetylcysteine Review and Acetylcysteine Label ).

4687491-6 | Burning Sensation, Erythema, Pruritus
on Jun 08, 2005 Female patient from , 83 years of age, weighting 108.0 lb, was diagnosed with urosepsis and was treated with Aztreonam (View Usage). After Aztreonam was administered, patient had the following side effects: burning sensation, erythema, pruritus. Aztreonam dosage: 1 Gram Q 8 Hours Intravenou. Patient was hospitalized.